For instance, C‐C motif chemokine ligand 2/monocyte‐chemoattractant protein‐1 (CCL2/MCP1) is known to substantially increase after diverse cerebrovascular diseases including ischemic stroke, and its levels even positively correlate with detrimental patients' outcome (Geng et al, 2022). Here, CCL2 is linked to ischemic stroke.